MPWT
NBIX icon

MassMutual Private Wealth & Trust’s Neurocrine Biosciences NBIX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.7K Buy
396
+8
+2% +$1.19K ﹤0.01% 689
2026
Q1 		$51.1K Sell
388
-118
-23% -$15.7K ﹤0.01% 760
2025
Q4 		$71.8K Buy
506
+7
+1% +$1.01K ﹤0.01% 683
2025
Q3 		$70K Buy
499
+7
+1% +$948 ﹤0.01% 695
2025
Q2 		$61.8K Sell
492
-66
-12% -$7.57K ﹤0.01% 720
2025
Q1 		$61.7K Buy
558
+27
+5% +$3.42K ﹤0.01% 674
2024
Q4 		$72.5K Buy
531
+157
+42% +$19.4K ﹤0.01% 645
2024
Q3 		$43.1K Sell
374
-138
-27% -$18.9K ﹤0.01% 696
2024
Q2 		$70.5K Buy
512
+155
+43% +$21.3K ﹤0.01% 575
2024
Q1 		$49.2K Buy
357
+11
+3% +$1.5K ﹤0.01% 623
2023
Q4 		$45.6K Buy
346
+9
+3% +$1.04K ﹤0.01% 626
2023
Q3 		$37.9K Buy
337
+86
+34% +$9.06K ﹤0.01% 661
2023
Q2 		$23.7K Buy
251
+72
+40% +$7.04K ﹤0.01% 721
2023
Q1 		$18.1K Buy
179
+13
+8% +$1.35K ﹤0.01% 759
2022
Q4 		$20K Buy
166
+6
+4% +$703 ﹤0.01% 637
2022
Q3 		$17K Buy
160
+99
+162% +$10K ﹤0.01% 617
2022
Q2 		$6K Sell
61
-11
-15% -$1.01K ﹤0.01% 847
2022
Q1 		$7K Buy
72
+63
+700% +$5.34K ﹤0.01% 841
2021
Q4 		$1K Buy
+9
New +$828 ﹤0.01% 1262
2020
Q3 		– Sell
-6
Closed -$1K – 792
2020
Q2 		$1K Buy
+6
New +$663 ﹤0.01% 702
2017
Q2 		– Sell
-10
Closed -$433 – 1075
2017
Q1 		$433 Sell
10
-55
-85% -$2.36K ﹤0.01% 959
2016
Q4 		$2.52K Buy
+65
New +$2.94K ﹤0.01% 574
2016
Q2 		$221K Buy
4,863
+95
+2% +$4.37K 0.03% 304
2016
Q1 		$189K Buy
+4,768
New +$189K 0.03% 294

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

MassMutual Private Wealth & Trust's NBIX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Neurocrine Biosciences (NBIX) stake by 2.1% in Q2 2026, buying an estimated $1.19K and bringing the position to 396 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

MassMutual Private Wealth & Trust first reported a position in NBIX in Q1 2016 and has held it in 24 quarters since. The position peaked at $221K in Q2 2016. 260 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 396 shares of Neurocrine Biosciences worth $66.7K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 8 Neurocrine Biosciences shares in Q2 2026, an estimated $1.19K.
  • Neurocrine Biosciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #689 holding.
  • MassMutual Private Wealth & Trust first reported a position in Neurocrine Biosciences in Q1 2016 and has held it in 24 quarters since.
  • MassMutual Private Wealth & Trust's Neurocrine Biosciences position peaked at $221K in Q2 2016.
  • 260 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.